8 minutes | Apr 16, 2021

Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation for COVID-19 Patients

A randomized, open-label, trial conducted to evaluate the effects of intermediate-dose vs standard-dose prophylactic anticoagulation among patients with COVID-19 admitted to the intensive care unit (ICU).
Play
Like
Play Next
Mark
Played
Share